{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:49:21Z","timestamp":1773305361509,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":3508,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1038\/sj.mt.6300075","type":"journal-article","created":{"date-parts":[[2007,1,16]],"date-time":"2007-01-16T23:43:57Z","timestamp":1168991037000},"page":"618-627","source":"Crossref","is-referenced-by-count":14,"title":["Multiple Reduced-intensity Conditioning Regimens Facilitate Correction of Fabry Mice After Transplantation of Transduced Cells"],"prefix":"10.1016","volume":"15","author":[{"given":"Sheng-Ben","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Yoshimitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando","family":"Poeppl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa I","family":"Rasaiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhui","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel H","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A","family":"Medin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/sj.mt.6300075_bib1","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1126\/science.1070104","article-title":"Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning","volume":"296","author":"Aiuti","year":"2002","journal-title":"Science"},{"key":"10.1038\/sj.mt.6300075_bib2","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMoa012616","article-title":"Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy","volume":"346","author":"Hacein-Bey-Abina","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.mt.6300075_bib3","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(04)17590-9","article-title":"Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector","volume":"364","author":"Gaspar","year":"2004","journal-title":"Lancet"},{"key":"10.1038\/sj.mt.6300075_bib4","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.ymthe.2004.08.006","article-title":"Sustained phenotypic correction of hemophilia A mice following oncoretroviral-mediated expression of a bioengineered human factor VIII gene in long-term hematopoietic repopulating cells","volume":"10","author":"Moayeri","year":"2004","journal-title":"Mol Ther"},{"key":"10.1038\/sj.mt.6300075_bib5","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1182\/blood.V99.9.3169","article-title":"Functional amelioration of murine galactosialidosis by genetically modified bone marrow hematopoietic progenitor cells","volume":"99","author":"Leimig","year":"2002","journal-title":"Blood"},{"key":"10.1038\/sj.mt.6300075_bib6","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","article-title":"Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency","volume":"276","author":"Brady","year":"1967","journal-title":"N Engl J Med"},{"issue":"suppl. 2","key":"10.1038\/sj.mt.6300075_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1023\/A:1012455421014","article-title":"Gene therapy for Fabry disease","volume":"24","author":"Siatskas","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1038\/sj.mt.6300075_bib8","series-title":"The Metabolic and Molecular Bases of Inherited Diseases","first-page":"2741","article-title":"\u03b1-Galactosidase a deficiency: Fabry disease","author":"Desnick","year":"1995"},{"key":"10.1038\/sj.mt.6300075_bib9","doi-asserted-by":"crossref","first-page":"7917","DOI":"10.1073\/pnas.93.15.7917","article-title":"Correction in trans for Fabry disease: expression, secretion and uptake of \u03b1-galactosidase A in patient-derived cells driven by a high-titer recombinant retroviral vector","volume":"93","author":"Medin","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.mt.6300075_bib10","doi-asserted-by":"crossref","first-page":"7515","DOI":"10.1073\/pnas.120177997","article-title":"Long-term enzyme correction and lipid reduction in multiple organs of primary and secondary transplanted Fabry mice receiving transduced bone marrow cells","volume":"97","author":"Takenaka","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.mt.6300075_bib11","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1089\/10430349950017293","article-title":"Circulating \u03b1-galactosidase A derived from transduced bone marrow cells: relevance for corrective gene transfer for Fabry disease","volume":"10","author":"Takenaka","year":"1999","journal-title":"Hum Gene Ther"},{"key":"10.1038\/sj.mt.6300075_bib12","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1073\/pnas.061020598","article-title":"Preselective gene therapy for Fabry disease","volume":"98","author":"Qin","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.mt.6300075_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human \u03b1-galactosidase A\u2014replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.mt.6300075_bib14","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1038\/sj.mt.6300075_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1089\/hum.2005.16.68","article-title":"Impact of humoral immune response on distribution and efficacy of recombinant adeno-associated virus-derived acid \u03b1-glucosidase in a model of glycogen storage disease type II","volume":"16","author":"Cresawn","year":"2005","journal-title":"Hum Gene Ther"},{"key":"10.1038\/sj.mt.6300075_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jss.2004.06.010","article-title":"HIV-based vectors and angiogenesis following rabbit hindlimb ischemia","volume":"123","author":"Conklin","year":"2005","journal-title":"J Surg Res"},{"key":"10.1038\/sj.mt.6300075_bib17","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1182\/blood-2005-08-3503","article-title":"Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation","volume":"107","author":"Berger","year":"2006","journal-title":"Blood"},{"key":"10.1038\/sj.mt.6300075_bib18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S1083-8791(00)70041-3","article-title":"An immunoablative regimen of fludarabine and cyclophosphamide prevents fully MHC-mismatched murine marrow graft rejection independent of GVHD","volume":"6","author":"Petrus","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1038\/sj.mt.6300075_bib19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1006\/mthe.2000.0050","article-title":"IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector","volume":"1","author":"Mizuguchi","year":"2000","journal-title":"Mol Ther"},{"key":"10.1038\/sj.mt.6300075_bib20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00019052-199904000-00007","volume":"12","author":"Krivit","year":"1999","journal-title":"Curr Opin Neurol"},{"key":"10.1038\/sj.mt.6300075_bib21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1034\/j.1399-3046.2002.02026.x","article-title":"Allogeneic bone marrow transplantation for infantile globoid-cell leukodystrophy (Krabbe's disease)","volume":"6","author":"Caniglia","year":"2002","journal-title":"Pediatr Transplant"},{"key":"10.1038\/sj.mt.6300075_bib22","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1023\/B:BOLI.0000009950.81514.c8","article-title":"Niemann-Pick disease: sixteen-year follow-up of allogeneic bone marrow transplantation in a type B variant","volume":"26","author":"Victor","year":"2003","journal-title":"J Inherit Metab Dis"},{"key":"10.1038\/sj.mt.6300075_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/01241398-200401000-00019","article-title":"Musculoskeletal manifestations of Hurler syndrome: long-term follow-up after bone marrow transplantation","volume":"24","author":"Weisstein","year":"2004","journal-title":"J Pediatr Orthop"},{"key":"10.1038\/sj.mt.6300075_bib24","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1182\/blood.V86.3.1218.1218","article-title":"Transfer of the human glucocerebrosidase gene into hematopoietic stem cells of nonablated recipients: successful engraftment and long-term expression of the transgene","volume":"86","author":"Schiffmann","year":"1995","journal-title":"Blood"},{"key":"10.1038\/sj.mt.6300075_bib25","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1182\/blood-2002-06-1649","article-title":"Nonmyeloablative conditioning is sufficient to allow engraftment of EGFP-expressing bone marrow and subsequent acceptance of EGFP-transgenic skin grafts in mice","volume":"101","author":"Andersson","year":"2003","journal-title":"Blood"},{"key":"10.1038\/sj.mt.6300075_bib26","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.bcmd.2004.06.007","article-title":"Stable long-term gene correction with low-dose radiation conditioning in murine X-linked chronic granulomatous disease","volume":"33","author":"Goebel","year":"2004","journal-title":"Blood Cells Mol Dis"},{"key":"10.1038\/sj.mt.6300075_bib27","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1073\/pnas.94.6.2540","article-title":"alpha-Galactosidase A deficient mice: a model of Fabry disease","volume":"94","author":"Ohshima","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.mt.6300075_bib28","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1182\/blood.V87.5.1754.1754","article-title":"A bicistronic therapeutic retroviral vector enables sorting of transduced CD34+ cells and corrects the enzyme deficiency in cells from Gaucher patients","volume":"87","author":"Medin","year":"1996","journal-title":"Blood"},{"key":"10.1038\/sj.mt.6300075_bib29","first-page":"22","article-title":"Bone marrow transplants come of age. New hope for deadly diseases","volume":"34","author":"Meadows","year":"2000","journal-title":"FDA Consum"},{"key":"10.1038\/sj.mt.6300075_bib30","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0022-2275(20)41686-4","article-title":"Quantitative analysis of plasma neutral glycosphingolipids by high performance liquid chromatography of their perbenzoyl derivatives","volume":"18","author":"Ullman","year":"1977","journal-title":"J Lipid Res"},{"key":"10.1038\/sj.mt.6300075_bib31","doi-asserted-by":"crossref","first-page":"6423","DOI":"10.1073\/pnas.96.11.6423","article-title":"Aging accentuates and bone marrow transplantation ameliorates metabolic defects in Fabry disease mice","volume":"96","author":"Ohshima","year":"1999","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616313235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616313235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T18:01:38Z","timestamp":1628359298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616313235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S1525001616313235"],"URL":"https:\/\/doi.org\/10.1038\/sj.mt.6300075","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}